Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare…

The Care Anywhere podcast is spotlighting a new global partnership designed to strengthen pediatric nursing education and recognition worldwide. In this episode, host Lea Sims sits down with leaders from TruMerit and the National Association of Pediatric Nurse Practitioners (NAPNAP) to unpack a new pediatric nursing micro-credential pathway launching in 2026, and why it…

Dementia is becoming one of healthcare’s most difficult problems to ignore. As the population ages, more families are finding themselves responsible for loved ones who can no longer manage their own care, communicate symptoms clearly, or navigate the healthcare system. Research shows that people living with dementia are hospitalized far more often than those without it—even…